Mindmed to present at h.c. wainwright 23rd annual global investment conference

New york, sept. 10, 2021 /prnewswire/ -- mind medicine (mindmed) inc. (nasdaq: mnmd), (neo: mmed), (de: mmq) (the "company"), a leading biotech company developing psychedelic-inspired therapies, is pleased to announce that robert barrow, chief executive officer of mindmed, will present at the virtual h.c.
MNMD Ratings Summary
MNMD Quant Ranking